Want to create an interactive transcript for this episode?
Podcast: Investor Connect Podcast
Episode: Investor Connect 830: Family Office Roundtable - March 2025 Part 03
Description: In this episode of Investor Connect, we welcome Ken from Synaptically, who introduces a groundbreaking personalized therapy for Alzheimer's disease. He discusses their innovative use of Transcranial Magnetic Stimulation (TMS) paired with Electroencephalograms (EEG) to achieve unprecedented results in slowing down disease progression. With two successful phase two clinical trials and strong validation from scientific experts, the therapy shows significant improvements in cognition, function, and behavior in patients. Ken explains how their technology targets neuroplasticity, creating new brain connections and preserving brain microstructure and gray matter volume, with minimal side effects. The discussion also touches on Synaptically's strong financials, market...